Cargando…
Strong antitumor efficacy of a pancreatic tumor‐targeting oncolytic adenovirus for neuroendocrine tumors
Although oncolytic adenoviruses are promising cancer therapy agents, for effective oncolytic activity, viruses need to specifically infect and effectively replicate in cancer cells but not in normal cells. We have previously identified a pancreatic cancer‐targeting ligand, SYENFSA (SYE), by screenin...
Autores principales: | Yamamoto, Yuki, Nagasato, Masaki, Rin, Yosei, Henmi, Marina, Ino, Yoshinori, Yachida, Shinichi, Ohki, Rieko, Hiraoka, Nobuyoshi, Tagawa, Masatoshi, Aoki, Kazunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633550/ https://www.ncbi.nlm.nih.gov/pubmed/28941156 http://dx.doi.org/10.1002/cam4.1185 |
Ejemplares similares
-
Cross-talk among MEN1, p53 and Notch regulates the proliferation of pancreatic neuroendocrine tumor cells by modulating INSM1 expression and subcellular localization
por: Capodanno, Ylenia, et al.
Publicado: (2021) -
A vicious partnership between AKT and PHLDA3 to facilitate neuroendocrine tumors
por: Takikawa, Masahiro, et al.
Publicado: (2017) -
An Infection-enhanced Oncolytic Adenovirus Secreting H. pylori Neutrophil-activating Protein with Therapeutic Effects on Neuroendocrine Tumors
por: Ramachandran, Mohanraj, et al.
Publicado: (2013) -
Oncolytic adenoviruses: A potent form of tumor immunovirotherapy
por: Cerullo, Vincenzo, et al.
Publicado: (2012) -
Immunotherapeutic intervention with oncolytic adenovirus in mouse mammary tumors
por: Gibson, Heather, et al.
Publicado: (2015)